- 英文名称
- Vinorelbine tartrate
- 分子式
- C53H66N4O20
- 分子量
- 1079.11
- 中文别名
- 长春瑞宾双酒石酸盐; 长春瑞滨; 洒石酸长春瑞宾; 长春瑞滨酒石酸酯(盐); 有丝分裂抑制剂(HELA细胞增殖抑制剂); 重酒石酸长春瑞滨; (3aR,3a1R,4R,5S,5aR,10bR)-4-乙酰氧基-3a-乙基-9-((8R)-4-乙基-8-(甲氧基羰基)-1,3,6,7,8,9-六氢-2,6-methanoazecino[4,3-b]吲哚-8-基)-5-羟基-8-甲氧基-6-甲基-3a,3a1,4,5,5a,6,11,12-八氢-1H-吲哚嗪并[8,1-cd]咔唑-5-甲酸甲酯 双((2R,3R)-2,3-二羟基琥珀酸盐); 3′,4′-Didehydro-4′-deoxy-C′-norvincaleukoblastine [R-(R*,R*)-2-3-dihydroxybutanedioate (1:2)salt]; 5′-Noranhydrovinoblastine tartrate; KW-2307; NVB; Navelbine tartrate; VINORELBINE TARTRATE, NAVELBINE; vinorelbine L-tartrate; Vinorelbine Ditartrate; Vinorelbine ditartrate salt; Methyl (3aR,3a1R,4R,5S,5aR,10bR)-4-acetoxy-3a-ethyl-9-((8R)-4-ethyl-8-(methoxycarbonyl)-1,3,6,7,8,9-hexahydro-2,6-methanoazecino[4,3-b]indol-8-yl)-5-hydroxy-8-methoxy-6-methyl-3a,3a1,4,5,5a,6,11,12-octahydro-1H-indolizino[8,1-cd]carbazole-5-carboxylate bis((2R,3R)-2,3-dihydroxysuccinate); Vinorelbine Ditartarate; Nor-5'-anhydrovinblastine ditartrate; Eunades; Vinorelbine (ditartrate)
- 用途
- 作为抗肿瘤原料药,用于治疗非小细胞肺癌、乳腺癌、卵巢癌、头颈部磷癌、白血病等;也用于含量测定、鉴定、药理实验等;是长春碱衍生物,作用机制为与微管蛋白结合,使细胞有丝分裂中微管形成障碍,为M期特异性药物,神经毒性较低。